ArticleAlzheimer's & dementia (New York, N. Y.)

Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer's disease.

Sarah M Hartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.